FERVAY? 1.5 g

Biocon offers a wide range of comprehensive care which includes fervay 1.5 g. Composition: each vial contains: sterile cefuroxime sodium ip, eq. To cefuroxime 1.5 g. Mechanism of action: cefuroxime inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (pbp?s). This in turn inhibits the final trans-peptidation step of peptidoglycan synthesis in bacterial cell walls, which results in cell wall synthesis. Eventually the sensitive bacteria get lysed due to ongoing activity of cell wall autolytic enzymes (autolysins & murein hydrolases) while cell wall assembly is arrested. Indications: lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, septicaemiaryngitis/tonsillitis, acute bacterial otitis media, acute bacterial maxillary sinusitis, acute bacterial exacerbations of chronic bronchitis and secondary bacterial infections of acute bronchitis